trans-10,cis-12 Conjugated Linoleic Acid Reduces Insulin-Like Growth Factor-II Secretion in HT-29 Human Colon Cancer Cells

Journal of Medicinal Food

Volumn 6, Issue 3, 2003, Pages 193-199

  Cho, Han Jin ^a   Lee, Hyun Sook ^a   Chung, Cha Kwon ^a   Kang, Young Hee ^a   Ha, Yeong Lae ^b   Park, Hyun Suh ^c   Park, Jung Han Yoon ^a  

^a Hallym University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Colon cancer cells; Conjugated linoleic acid; Insulin like growth factor binding proteins; Insulin like growth factor II

Indexed keywords

LINOLEIC ACID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CONJUGATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INCUBATION TIME; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM;

EID: 0344413655     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/10966200360716607     Document Type: Article

References (37)

1. Kritchevsky D: Antimutagenic and some other effects of conjugated linoleic acid. Br J Nutr 2000;83:459-465.
2. Belury MA: Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action. J Nutr 2002;132:2995-2998.
3. Pariza, MW, Park Y, Cook ME: Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci 1999;52:107-110.
4. Park HS, Ryu JH, Ha YL, Park JHY: Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: A possible mechanism of the anti-carcinogenic effect by CLA. Br J Nutr 2001;86:549-555.
5. O'Shea M, Stanton C, Devery R: Antioxidant enzyme defence responses of human MCF-7 and SW480 cancer cells to conjugated linoleic acid. Anticancer Res 1999;19:1953-1959.
6. Shultz TD, Chew BP, Seaman WR, Luedecke LO: Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett 1992;63:125-133.
7. Jones, JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
8. Stewart CE, Rotwein P: Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-1026.
9. Baxter RC: Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000;278:E967-E976.
10. Hwa V, Oh Y, Rosenfeld RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999;20:761-787.
11. Yu H, Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-1489.
12. Singh P, Rubin N: Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology 1993;105:1218-1237.
13. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 1997;276:1268-1272.
14. Mishra L, Bass B, Ooi B, Sidawy A, Korman L: Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. Growth Horm IGF Res 1998.8:473-479.
15. Renehan AG, Painter JE, O'Halloran D, Atkins WS, Potten CS, O'Dwyer ST, Shalet SM: Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab 2000;85:3402-3408.
16. Guo Y, Narayan S, Yallampalli C, Singh P: Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology 1992;102:1101-1108.
17. Oh YS, Kim EJ, Schaffer BS, Kang YH, Binderup L, MacDonald RG, Park JHY: Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells. Mol Cell Endocrinol 2001;183:141-149.
18. Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N: Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II, and transforming growth factor alpha. Br J Cancer 1992;65:341-346.
19. Kim EJ, Cho HJ, Kim SJ, Kang YH, Ha YL, Park JHY: Effect of conjugated linoleic acid on the proliferation of the human colon cancer cell line, HT-29. Korean J Nutr 2001;34:896-904.
20. Kim EJ, Kim WY, Kang H, Ha YL, Bach L, Park JHY: Inhibition of Caco-2 cell proliferation by (n3) fatty acids: possible mediation by increased secretion of insulin-like growth factor binding protein-6. Nutr Res 2000;20:1409-1421.
21. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival: modifications of the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-277.
22. Kim EJ, Kang Y-H, Schaffer BS, Bach LA, MacDonald RG, Park JHY: Inhibition of Caco-2 cell proliferation by all-trans retinoic acid (tRA): Role of insulin-like growth factor binding protein-6. J Cell Physiol 2002;190:92-100.
23. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and protein from cell and tissue samples. Biotechniques 1993;15:532-537.
24. Kwon YH, Jovanovic A, Serfas MS, Kiyokawa H, Tyner AL: P21 functions to maintain quiescence of p27-deficient hepatocytes. J Biol Chem 2002;277:41417-41422.
25. Steel RGD, Torrie JH: Principles and Procedures of Statistics, 2nd ed. McGraw-Hill, New York, 1980.
26. Tanaka H, Asami O, Hayano T, Sasaki I, Yoshitake Y, Moshikawa K: Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial cell line 18,54-SF: Application of a monoclonal antibody. Endocrinology 1989;124:870-877.
27. Culouscou JM, Remacle-Bonnet M, Carrouste F, Fantini J, Marvaldi J, Pommier G: Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line. J Cell Physiol 1990;143:405-415.
28. Pariza MW, Ha YL, Benjamin H, Sword JT, Gruter A, Chin SF, Storkson J, Faith N, Albright K: Formation and action of anti-carcinogenic fatty acids. Adv Exp Med Biol 1991;289:269-272.
29. Liu KL, Belury MA: Conjugated linoleic acid reduces arachidonic acid content and PGE2 synthesis in murine keratinocytes. Cancer Lett 1998;127:15-22.
30. Bulgarella JA, Patton D, Bull AW: Modulation of prostaglandin H synthase activity by conjugated linoleic acid (CLA) and specific CLA isomers. Lipids 2001;36:407-412.
31. Nugteren DH: Inhibition of prostaglandin biosynthesis by 8cis, 12trans, 14cis-eicosatrienoic acid and 5cis, 8cis, 12trans, 14cis-eicosatetraenoic acid. Biochim Biophys Acta 1970;210:171-176.
32. Nugteren DH, Christ-Hazelhof E: Naturally occurring conjugated octadecatrienoic acids are strong inhibitors of prostaglandin biosynthesis. Prostaglandins 1987;33:403-417.
33. Thomas MJ, Umayahara Y, Shu H, Centrella M, Rotwein P, Mc-Carthy TL: Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J Biol Chem 1996;271:21835-21841.
34. Ricchi P, Pignata S, Di Popolo A, Memoli A, Apicella A, Zarrilli R, Acquaviva AM: Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer 1997;73:880-884.
35. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998;244:678-682.
36. Park JHY, Corkins MR, Vanderhoof JA, Caruso NM, Hrbek M J, Schaffer BS, Slentz DH, McCusker RH, MacDonald RG: Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation. J Cell Physiol 1996;166:396-406.
37. Miraki-Moud F, Chrysis D, King P, Camacho-Hubner C: Insulin-like growth factor binding protein-2 (IGFBP-2) stimuates proliferation and decreases apoptosis in Caco-2 colon cancer cells. In: Endocrine Society 83rd Annual Meeting, Program & Abstracts, Endocrine Society, Denver, CO, 2001, PI-196.